drugset / Trial / NCT03392623

DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.

NCT03392623

Phase 0 Completed 28 enrolled Autonomous University of San Luis Potosí
RandomizedParallel-groupDouble-blindOther

Summary

BACKGROUND: Malar melasma has a chronic and recurrent character that may be related with epigenetic changes.

Timeline

Start
2015-01-01
Primary completion
2016-01-01
Completion
2016-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Isotretinoin Other / unclassified 0.05 % Other
Subject Nicotinamide Other / unclassified 4 % Other
Comparator Sunscreen Unknown Other